Brief Description
The iDEA-TECH 2025-2026 Scope of the Call seeks innovative technology partnerships across seven thematic areas that leverage AI/ML and fifteen cutting-edge platforms to accelerate precision medicine and therapeutic development. The call emphasizes technologies that can advance drug discovery and development across Sanofi's key therapeutic areas: Immunology (including autoimmune and inflammatory diseases), Oncology, Neurology (including Alzheimer's, Parkinson's, and ALS), Ophthalmology (including AMD, glaucoma, and diabetic retinopathy)
Within each thematic area, sub-categories represent internal teams seeking partnership in that thematic area.